Mammary Tumor Virus, Mouse
"Mammary Tumor Virus, Mouse" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The type species of BETARETROVIRUS commonly latent in mice. It causes mammary adenocarcinoma in a genetically susceptible strain of mice when the appropriate hormonal influences operate.
Descriptor ID |
D008324
|
MeSH Number(s) |
B04.613.807.124.500 B04.820.650.124.500
|
Concept/Terms |
Mammary Tumor Virus, Mouse- Mammary Tumor Virus, Mouse
- Mammary Cancer Virus
- Mammary Tumor Viruses, Mouse
- Bittner Virus
- Mouse mammary tumor virus
|
Below are MeSH descriptors whose meaning is more general than "Mammary Tumor Virus, Mouse".
Below are MeSH descriptors whose meaning is more specific than "Mammary Tumor Virus, Mouse".
This graph shows the total number of publications written about "Mammary Tumor Virus, Mouse" by people in this website by year, and whether "Mammary Tumor Virus, Mouse" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
2010 | 0 | 1 | 1 | 2011 | 0 | 1 | 1 | 2012 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Mammary Tumor Virus, Mouse" by people in Profiles.
-
Mazumdar A, Medina D, Kittrell FS, Zhang Y, Hill JL, Edwards DE, Bissonnette RP, Brown PH. The combination of tamoxifen and the rexinoid LG100268 prevents ER-positive and ER-negative mammary tumors in p53-null mammary gland mice. Cancer Prev Res (Phila). 2012 Oct; 5(10):1195-202.
-
Owens P, Pickup MW, Novitskiy SV, Chytil A, Gorska AE, Aakre ME, West J, Moses HL. Disruption of bone morphogenetic protein receptor 2 (BMPR2) in mammary tumors promotes metastases through cell autonomous and paracrine mediators. Proc Natl Acad Sci U S A. 2012 Feb 21; 109(8):2814-9.
-
Lynn KD, Udugamasooriya DG, Roland CL, Castrillon DH, Kodadek TJ, Brekken RA. GU81, a VEGFR2 antagonist peptoid, enhances the anti-tumor activity of doxorubicin in the murine MMTV-PyMT transgenic model of breast cancer. BMC Cancer. 2010 Jul 30; 10:397.
|
People People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|